Study found that the proportion of Treg and the levels of IL-10 and TGF-β are higher in the peripheral blood of leukemia patients as compared to those of healthy control subjects, and confirmed that IL-10 and TGF-β produced by Treg could inhibit the proliferation of effector T cell proliferation in vitro [13]. Here, TGFB1 is linked to leukemia.